Using the integrated strategy of network pharmacology and greedy algorithms, the important roles of some targets IL6, HMCGR, PPARA, and APOB for management of hyperlipidemia and obesity were highlighted in this work, which was also in accord with the previous publications. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.